Using a target trial emulation framework, researchers analyzed Truveta Data and compared adults with alcohol use disorder (AUD) and either type 2 diabetes or obesity who started a newer GLP-1 RA (semaglutide, tirzepatide) to similar individuals starting alternative medications
The nutrition gap that produced the plateau existed from day one
Lipo B is the cheaper component, but its a recurring expense that adds 1030% to your total monthly cost
the placebo and empagliflozin groups were treated with the respective monotherapy for 32 weeks
For many eligible patients, they can provide meaningful appetite control and support significant weight loss
For Hims, it strengthens their value proposition, enhances their growth strategy, and positions Hims as a leader in telehealth